A novel optical metabolic assay of cancer drug efficacy in primary 3d tumor cultures

Alex Walsh, Rebecca S. Cook, Carlos L. Arteaga, Melissa C. Skala

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Optical metabolic imaging of 3-dimensional cultures derived from primary human breast cancer tissue samples resolves cellular level response to cancer drugs and drug combinations. This approach could provide a powerful high-throughput drug screen for primary human tumors.

Original languageEnglish (US)
Title of host publicationOptical Molecular Probes, Imaging and Drug Delivery, OMP 2013
PublisherOptical Society of America (OSA)
PagesMT3C.3
ISBN (Print)9781557529664
DOIs
StatePublished - Jan 1 2013
EventOptical Molecular Probes, Imaging and Drug Delivery, OMP 2013 - Waikoloa Beach, HI, United States
Duration: Apr 14 2013Apr 18 2013

Publication series

NameOptical Molecular Probes, Imaging and Drug Delivery, OMP 2013

Other

OtherOptical Molecular Probes, Imaging and Drug Delivery, OMP 2013
CountryUnited States
CityWaikoloa Beach, HI
Period4/14/134/18/13

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Atomic and Molecular Physics, and Optics

Fingerprint Dive into the research topics of 'A novel optical metabolic assay of cancer drug efficacy in primary 3d tumor cultures'. Together they form a unique fingerprint.

  • Cite this

    Walsh, A., Cook, R. S., Arteaga, C. L., & Skala, M. C. (2013). A novel optical metabolic assay of cancer drug efficacy in primary 3d tumor cultures. In Optical Molecular Probes, Imaging and Drug Delivery, OMP 2013 (pp. MT3C.3). (Optical Molecular Probes, Imaging and Drug Delivery, OMP 2013). Optical Society of America (OSA). https://doi.org/10.1364/omp.2013.mt3c.3